| Video
A clinical pharmacy specialist turns the spotlight on an option for chronic pain management that many clinicians may not have considered. Buprenorphine offers advantages to patients who are indicated for opioid therapy, but are at risk for adverse effects, While reimbursement is an issue, it...
| Video
One approach to maintaining the balance between risks and benefits of opioid therapy for chronic pain has been the development of abuse deterrent formulations. A pain management PA provides an overview of abuse deterrent technologies, both existing and emerging. While developments are encouraging...
| Article
Results of a recent review of 7 studies concludes that rotator cuff disease, a disorder that impacts up to one-half of people over age 50, may be linked to genetics. The condition is associated with loss of function and shoulder pain, and is usually connected to injury or sustained overuse. A...
| Podcast
There are over 16,000 deaths per year associated with opioid induced respiratory depression and overdose. These occur in the substance abuse population and also in chronic pain patients who are legitimately receiving opioids. This interactive lecture will review unexpected and unanticipated risks of...
| Podcast
Managing risk is an essential part of medical practice, particularly in light of the reported increase in morbidity and mortality associated with the use of opioids. Recent anecdotal data indicate that as a result of the "opioid crisis," patients are being told by their prescribers that they can no...
| Podcast
Fierce debates rage on about chronic pain. These include the utility of chronic opioid therapy, the value proposition of multidisciplinary approaches, reimbursement related issues, risk of aberrant drug related behaviors, along with many other questions related to assessment and treatment...
| Podcast
The prescribers of opioid medications for pain and addiction are under heavy scrutiny from state regulators, law enforcement, and plaintiffs' attorneys. With benzodiazepine related overdose deaths quadrupling between 2001 and 2013, and sedative induced impairment garnering increasing attention in...
| Video
UDT is the preferred tool in patient centered care, and is increasingly important in risk management. Heit and Gourlay discuss how it can offer clinicians insight into patient identification, treatment, and monitoring, and provide objective data for risk evaluation.
| Video
A number of validated risk assessment tools are available to the prescribing clinician, and their use is increasingly important in the current environment for opioid therapy. A clinical psychologist and Certified Pain Educator summarizes what the frontline practitioner should know about the pros and...
| Article
We know more now about the risk factors and patients who may be good candidates for naloxone. These would include patients on higher doses of opioids, patients with complicated comorbidities like renal or hepatic disease, sleep apnea, and most obviously, those with active substance abuse, or a...